Compounded Injectable Vial
A compounded dual GIP/GLP-1 injectable for medically supervised weight management. Prescribed only after a licensed provider reviews your health intake.
Rx only — requires provider review
Save $51.00
Purchase option
Not available in AR, AK, IN, MN, SC, CA — checkout enforces state eligibility.
Tirzepatide is a dual GIP/GLP-1 receptor agonist, supplied here as a compounded injectable vial. It works by activating two of the gut hormone pathways your body already uses to regulate appetite and blood sugar — helping you feel full sooner and stay satisfied longer between meals.
It is typically prescribed as part of a structured weight management plan for people who want a medication-supported approach alongside changes to diet and activity. Your provider determines whether it fits your health history and goals.
Treatment is managed under ongoing medical supervision, with your plan reviewed and adjusted by a licensed clinician over time. OpenDoseRx treatments are dispensed only after a licensed provider reviews your health intake and determines a prescription is appropriate for you.
How ordering works
Choose your strength
Pick the exact dose and pack size. You see the price before you commit — nothing is hidden until checkout.
A provider reviews your intake
Complete a short medical intake. An independent, licensed U.S. provider decides if it's appropriate — and if they decline, you're refunded in full.
Compounded and shipped
Approved orders are prepared by a licensed U.S. pharmacy and shipped discreetly to your door.
Semaglutide vs. tirzepatide: how GLP-1 and GIP/GLP-1 medications differ
A neutral, mechanism-focused comparison of two prescription incretin medications and the gut-hormone receptors they act on.
How GLP-1 medications interact with appetite and digestion
A neutral, mechanism-focused look at how GLP-1 receptor agonism engages the gut-brain satiety axis and the gastric-emptying signals tied to hunger and fullness.
Oral vs. injectable GLP-1 medications: how the routes differ
A neutral, mechanism-focused look at how injecting a GLP-1 peptide under the skin and absorbing one by mouth differ in absorption and bioavailability.
